Prostate Cancer Treatment Market is expected to reach $31.60 billion by 2034, with a CAGR of 8.5% during the forecast period

The Global Prostate Cancer Treatment Market Was Valued At Approximately USD 14.01 Billion In 2024. It Is Projected To Reach USD 31.60 Billion By 2034, Growing At A Compound Annual Growth Rate (CAGR) Of 8.5% From 2025 To 2034.

Market Introduction
Prostate cancer treatment involves surgery, radiation therapy, and medicines. Medications include hormone therapy, targeted therapy, chemotherapy, and immunotherapy. In many cases, other treatments are also used to cure prostate cancer. This may include ablation therapy, which uses heat or cold to destroy cancer cells, and the administration of radiation directly to cancer cells. The healthcare team considers factors such as the size of the tumor, whether it has spread, and how quickly it is growing.
The surgery for prostate cancer most frequently involves separating the prostate, which is known as prostatectomy. It is frequently utilized when cancer is only in the prostate. Often, it can cure the cancer that proliferates larger and spreads to the lymph nodes. In the course of the laparoscopic prostatectomy for prostate cancer, a surgeon makes many small incisions in the belly and puts surgical instruments through the cuts. The surgeon then utilizes the instruments to remove the prostate.

Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/prostate-cancer-treatment-market/request-for-sample

Competitive Landscape Analysis
Market firms are involved in advancing and commercializing inventive therapies involving hormonal cures, chemotherapy, immunotherapy, and targeted therapies to meet the developing requirements of patients worldwide. The report explores the key business players along with their in-depth profiling:

• AbbVie Inc.
• Amgen Inc.
• Astellas Pharma Inc.
• AstraZeneca Plc
• Bayer AG
• Bristol-Myers Squibb Company
• Dendreon Pharmaceuticals LLC
• Eli Lilly and Company
• Endo Pharmaceuticals Inc.
• Ipsen Pharma
• Johnson & Johnson Services, Inc.

Prostate Cancer Treatment Market Report Highlights:
• By drug class, the hormonal therapy segment holds the largest prostate cancer treatment market share due to its widespread use in treating advanced prostate cancer. However, the targeted therapy segment is expected to register the highest growth, driven by the increasing adoption of precision medicine and novel treatment options.

• By distribution channel, the hospital pharmacies segment dominates the prostate cancer treatment market revenue share, primarily due to their role in dispensing specialized treatments, especially for advanced cancer. However, the online pharmacies segment is witnessing the highest growth, fueled by the rise of digital health platforms and the convenience of home delivery.

Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/prostate-cancer-treatment-market/request-for-discount-pricing

Market Drivers
Growing Prevalence of Prostate Cancer: The prevalence of prostate cancer is surging notably globally. As per the World Health Organization (WHO), prostate cancer is amongst the most common cancers in men, with 1.4 million cases detected globally in 2020. Factors such as aging population and enhanced diagnostic potential lead to a growing number of diagnoses. The growing prevalence of this illness has escalated the demand for productive cures, propelling the prostate cancer treatment market forward.
Enhanced Imaging Techniques: Improved imaging methodologies such as multiparametric MRI and PSMA PET-CT, have enhanced premature discernment and staging preciseness of the cancer. For therapeutics, inventions such as radiopharmaceuticals, robotic-assisted surgeries, and targeted therapies are becoming more approachable.

Segmentation Outlook
By Drug Class Outlook (Revenue - USD Billion, 2020-2034)
• Hormonal Therapy
• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Others

By Distribution Channel Outlook (Revenue - USD Billion, 2020-2034)
• Hospital Pharmacies
• Drug Stores & Retail Pharmacies
• Online Pharmacies

Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/prostate-cancer-treatment-market

Geographical Landscape
Regionally, the prostate cancer treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
North America accounted for the largest prostate cancer market share due to the elevated existence of prostate cancer and progressive healthcare framework.
Asia Pacific followed North America as being a significant regional entity due to growing healthcare funding and the surging existence of the illness.

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

More Trending Latest Reports by Polaris Market Research:
Breathalyzers Market
https://www.polarismarketresearch.com/industry-analysis/breathalyzer-market

Anticoagulant Reversal Drugs Market
https://www.polarismarketresearch.com/industry-analysis/anticoagulant-reversal-drugs-market

Biotech Ingredients Market
https://www.polarismarketresearch.com/industry-analysis/biotech-ingredients-market

Remote Surgery Technology Platforms Market
https://www.polarismarketresearch.com/industry-analysis/remote-surgery-technology-platforms-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.